Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

You are here: Industry Insights > PharmaCyte

News List

PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering firstwordpharma
August 03, 2021
PharmaCyte Biotech, Inc. (OTCQB: PMCBD) (PharmaCyte or Company) today announced that The Nasdaq Stock Market LLC (Nasdaq) has approved the listing of the Company's common stock on Nasdaq.
PharmaCyte Conducts Final Audit of Mfg. Facility contractpharma
May 19, 2020
PharmaCyte Biotech, a biotechnology company focused on developing cellular therapies for cancer and diabetes, has announced that cGMP Validation, the company’s GMP consultant, is conducting its final audit of the manufacturing facility in Thailand.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2024 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go

PharmaSources Customer Service